BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 12617973)

  • 1. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
    Lorrain DS; Baccei CS; Bristow LJ; Anderson JJ; Varney MA
    Neuroscience; 2003; 117(3):697-706. PubMed ID: 12617973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
    Fell MJ; Katner JS; Johnson BG; Khilevich A; Schkeryantz JM; Perry KW; Svensson KA
    Neuropharmacology; 2010 Mar; 58(3):632-9. PubMed ID: 19951716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    Neuropharmacology; 2001 Jun; 40(7):847-55. PubMed ID: 11378155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMDA receptors in regulating group II metabotropic glutamate receptor-mediated long-term depression in rat medial prefrontal cortex.
    Huang CC; Hsu KS
    Neuropharmacology; 2008 Jun; 54(7):1071-8. PubMed ID: 18378263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex.
    Swanson CJ; Perry KW; Schoepp DD
    J Neurochem; 2004 Jan; 88(1):194-202. PubMed ID: 14675163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3.
    Pozzi L; Baviera M; Sacchetti G; Calcagno E; Balducci C; Invernizzi RW; Carli M
    Neuroscience; 2011 Mar; 176():336-48. PubMed ID: 21193020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
    Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
    Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.
    Kiritoshi T; Neugebauer V
    Neuropharmacology; 2015 Aug; 95():388-94. PubMed ID: 25912637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
    Imre G; Salomons A; Jongsma M; Fokkema DS; Den Boer JA; Ter Horst GJ
    Pharmacol Biochem Behav; 2006 Jul; 84(3):392-9. PubMed ID: 16857251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of dendritic release of dopamine by metabotropic glutamate receptors in rat substantia nigra.
    Campusano JM; Abarca J; Forray MI; Gysling K; Bustos G
    Biochem Pharmacol; 2002 Apr; 63(7):1343-52. PubMed ID: 11960611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
    Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell.
    Greenslade RG; Mitchell SN
    Neuropharmacology; 2004 Jul; 47(1):1-8. PubMed ID: 15165829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
    Butts KA; Phillips AG
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1799-807. PubMed ID: 23590841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.
    Yonezawa Y; Kuroki T; Kawahara T; Tashiro N; Uchimura H
    Eur J Pharmacol; 1998 Jan; 341(1):45-56. PubMed ID: 9489855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.
    Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y
    J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.